Fig. 1: Naringenin administration alleviates gestational diabetes mellitus (GDM) symptoms.
From: Naringenin improves insulin sensitivity in gestational diabetes mellitus mice through AMPK
a Maternal body weight was recorded on gestation day (GD) 0, 9, and 18 in wild-type group, GDM group, and GDM + NAR group. b Body weight gains were calculated from GD0 to GD18. c Serum glucose levels of each group were measured on GD0, 9, and 18. NAR, naringenin for short. n = 7–12 for each group. Data were presented as mean ± SD. #p < 0.05, ##p < 0.01, ###p < 0.001 compared with wild-type group. *p < 0.05, **p < 0.01 between the comparison of GDM group and GDM + NAR group
